Literature DB >> 6467800

Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system.

C H Kleinbloesem, J van Harten, L G de Leede, P van Brummelen, D D Breimer.   

Abstract

Nifedipine steady-state kinetics and dynamics were investigated in a placebo-controlled study of six healthy subjects. Nifedipine was given rectally through an osmotic system at a zero-order rate for 24 hr. Steady-state plasma concentrations of approximately 20 ng/ml were achieved within 6 to 8 hr. Nifedipine lowered diastolic blood pressure (DBP) and increased forearm blood flow (FBF) and plasma norepinephrine concentration. On the other hand, heart rate (HR) and systolic blood pressure were not affected. Changes in DBP and FBF were closely related to nifedipine plasma concentrations during and immediately after the infusion period. Our data indicate that nifedipine lowers blood pressure in subjects with normotension and that it is possible by infusing the drug at a relatively low rate to dissociate its effect on blood pressure from that on HR.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467800     DOI: 10.1038/clpt.1984.194

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  17 in total

Review 1.  Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

Authors:  P S Banerjee; J R Robinson
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 2.  Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.

Authors:  E J van Hoogdalem; A G de Boer; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

Review 3.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

4.  Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine.

Authors:  D R Robertson; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

5.  Oral absorption profile of nitrendipine in healthy subjects: a kinetic and dynamic study.

Authors:  P A Soons; A G de Boer; P van Brummelen; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

6.  Complexation of nifedipine with substituted phenolic ligands.

Authors:  K M Boje; M Sak; H L Fung
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

Review 7.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

8.  The effect of ageing on the disposition of nifedipine and atenolol.

Authors:  M Scott; C M Castleden; H K Adam; R P Smith; T J Fitzsimons
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

Review 9.  Nifedipine. Relationship between pharmacokinetics and pharmacodynamics.

Authors:  C H Kleinbloesem; P van Brummelen; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

10.  Influence of salicylate and anaesthesia on the rectal absorption of theophylline in rats.

Authors:  E J Van Hoogdalem; A G De Boer; D D Breimer
Journal:  Pharm Weekbl Sci       Date:  1986-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.